Evaluation of beta-adrenergic function in normal and asthmatic children

Area of Science:

• Immunology
• Pediatric Pulmonology
• Endocrinology

Background:

• Atopic individuals may exhibit reduced hyperglycemia following epinephrine administration.
• This phenomenon suggests a potential partial beta-adrenergic blockade in atopic conditions.
• Understanding this response is crucial for managing atopic diseases.

Purpose of the Study:

• To compare serum glucose levels after epinephrine injection in normal children and those with mild, moderate, and severe atopic asthma.
• To investigate the relationship between asthma severity and the body's glucose regulation response to beta-adrenergic stimulation.
• To explore evidence for partial beta-adrenergic blockade in atopy.

Main Methods:

• Serum glucose levels were measured using the glucose-oxidase method.
• Participants included non-atopic normal children and atopic asthmatic children across different severity levels.
• Epinephrine (1/1000) was administered subcutaneously, with glucose levels assessed at baseline, 30, and 60 minutes.

Main Results:

• Normal children showed significant glucose increases at 30 and 60 minutes post-epinephrine.
• Mild and moderate asthmatics had significant increases only at 30 minutes.
• Severe asthmatics displayed no significant increase at 30 minutes, with levels lower than at 60 minutes, and showed significant differences compared to normal children.

Conclusions:

• Children with severe atopic asthma exhibit a markedly diminished hyperglycemic response to epinephrine, indicating significant beta-adrenergic dysfunction.
• Moderate asthmatics also showed a reduced response compared to normal children.
• These findings highlight impaired beta-adrenergic pathways in atopic asthma, varying with disease severity.